Adicet Bio, Inc. (NASDAQ:ACET) Receives $14.50 Consensus Price Target from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […]
More Stories
Gulf States Say They’ve Shot Down More Than 1,500 Iranian Missiles, Drones
By John Haughey Five Persian Gulf nations that host U.S. military installations claim they have collectively shot down more than...
FBI Confirms Terrorism Task Force Investigating Texas Bar Shooting That Left 2 Dead
By Jack Phillips The FBI on March 1 stated that its terrorism task force has joined an investigation into a...
After Khamenei’s Death, Continued US–Israeli Strikes Push Iran’s Regime to Brink
By Emel Akan and Jacob Burg WASHINGTON—President Donald Trump on March 1 praised the joint U.S.–Israel military operation that killed...
Trump Announces US Military Sank 9 Iranian Navy Ships
By Jack Phillips President Donald Trump on Sunday afternoon said that the U.S. military has sunk nine Iranian naval ships...
State Department Urges Vigilance for Americans Overseas Amid Iran Conflict
By Bill Pan The U.S. Department of State is urging Americans worldwide, particularly those in the Middle East, to exercise...
Trump Admin Seeks Months-Long Pause on Tariff Refunds
By Bill Pan The Trump administration says it needs months of additional time to weigh its steps, as a wave...